Protocols in Revision

Acute Lymphoblastic Leukaemia

• GMALL-EVOLVE - ALL induction (day 6 Imatinib), 18 - 65 years, Ph/BCR-ABL+ PID 964 V2.0
• GMALL-EVOLVE - ALL Consolidation I (week 9 Imatinib), 18 - 65 years, Ph/BCR-ABL+ PID 966 V2.0

Acute Myeloid Leukemia

• Cytarabine 3000, Acute Myeloid Leukemia, consolidation, under 60 years, day 1-3 PID 995 V1.2

Anal Carcinoma

• Retifanlimab 500 / Paclitaxel 80 / Carboplatin 5 - Retifanlimab 500, Anal Carcinoma, maintenance PID 2869 V1.1
• Retifanlimab 500 / Paclitaxel 80 / Carboplatin 5, Anal Carcinoma PID 2868 V1.1

Hodgkin Lymphoma

• mini-BEAM - Carmustine 60 / Etoposide 75 / Cytarabine 100 / Melphalan 30, Hodgkin Lymphoma PID 2381 V1.1

Colon Cancer

• Modified FOLFOX-6/PNTM - Panitumumab 6 / Oxaliplain 85 / Folinic acid 400 / Fluorouracil 2400, Colorectal Carcinoma, induction PID 1989 V1.1

Multiple Myeloma

• HD 7 - Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20, Multiple Myeloma, Induction, Cycle 1-3 PID 40 V1.1
• HD 7 - Lenalidomide 10 / Dexamethasone 20, Multiple Myeloma, maintenance, cycle 1 PID 43 V1.1
• HD 7 - Lenalidomide 10, multiple myeloma, maintenance, cycle 2-3 PID 44 V1.1
• HD 7 - Lenalidomide 15, multiple myeloma, maintenance, cycle 4+ PID 37 V1.1